Literature DB >> 15020342

A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing.

M Pimentel1, D Wallace, D Hallegua, E Chow, Y Kong, S Park, H C Lin.   

Abstract

BACKGROUND: An association between irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO) has been found.
OBJECTIVE: To compare the prevalence and test results for bacterial overgrowth between IBS and fibromyalgia.
METHODS: Subjects with independent fibromyalgia and IBS were compared with controls in a double blind study. Participants completed a questionnaire, and a lactulose hydrogen breath test was used to determine the presence of SIBO. The prevalence of an abnormal breath test was compared between study participants. Hydrogen production on the breath test was compared between subjects with IBS and fibromyalgia. The somatic pain visual analogue score of subjects with fibromyalgia was compared with their degree of hydrogen production.
RESULTS: 3/15 (20%) controls had an abnormal breath test compared with 93/111 (84%) subjects with IBS (p<0.01) and 42/42 (100%) with fibromyalgia (p<0.0001 v controls, p<0.05 v IBS). Subjects with fibromyalgia had higher hydrogen profiles (p<0.01), peak hydrogen (p<0.0001), and area under the curve (p<0.01) than subjects with IBS. This was not dependent on the higher prevalence of an abnormal breath test. The degree of somatic pain in fibromyalgia correlated significantly with the hydrogen level seen on the breath test (r = 0.42, p<0.01).
CONCLUSIONS: An abnormal lactulose breath test is more common in fibromyalgia than IBS. In contrast with IBS, the degree of abnormality on breath test is greater in subjects with fibromyalgia and correlates with somatic pain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15020342      PMCID: PMC1754959          DOI: 10.1136/ard.2003.011502

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  40 in total

Review 1.  Gut microbiota and related diseases: clinical features.

Authors:  Vincenzo Stanghellini; Giovanni Barbara; Cesare Cremon; Rosanna Cogliandro; Alexandra Antonucci; Veronica Gabusi; Chiara Frisoni; Roberto De Giorgio; Valentina Grasso; Mauro Serra; Roberto Corinaldesi
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

2.  Neuroinflammation in fibromyalgia and CRPS is multifactorial.

Authors:  Alex Vasquez
Journal:  Nat Rev Rheumatol       Date:  2016-04       Impact factor: 20.543

Review 3.  Symptom overlap and comorbidity of irritable bowel syndrome with other conditions.

Authors:  Christine L Frissora; Kenneth L Koch
Journal:  Curr Gastroenterol Rep       Date:  2005-08

Review 4.  Microbiota and nonalcoholic steatohepatitis.

Authors:  Kento Imajo; Masato Yoneda; Yuji Ogawa; Koichiro Wada; Atsushi Nakajima
Journal:  Semin Immunopathol       Date:  2013-12-14       Impact factor: 9.623

5.  Small Intestinal Bacterial Overgrowth and Coronary Artery Disease: What Is in the CArDs?

Authors:  Christopher Adkins; Ali Rezaie
Journal:  Dig Dis Sci       Date:  2018-02       Impact factor: 3.199

Review 6.  Small intestinal bacterial overgrowth syndrome.

Authors:  Jan Bures; Jiri Cyrany; Darina Kohoutova; Miroslav Förstl; Stanislav Rejchrt; Jaroslav Kvetina; Viktor Vorisek; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

7.  Prevalence of restless legs syndrome in patients with irritable bowel syndrome.

Authors:  P Patrick Basu; N James Shah; Nithya Krishnaswamy; Tommy Pacana
Journal:  World J Gastroenterol       Date:  2011-10-21       Impact factor: 5.742

8.  Does frequency of restless legs syndrome and poor sleep quality increase with age in irritable bowel syndrome?

Authors:  Akif Acay; Ahmet Bal; Serdar Oruc; Taner Ozkececi; Muzaffer Sariaydin; Hayri Demirbas; Gursel Acarturk
Journal:  Wien Klin Wochenschr       Date:  2016-09-13       Impact factor: 1.704

9.  Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin.

Authors:  Sergio Peralta; Claudia Cottone; Tiziana Doveri; Piero Luigi Almasio; Antonio Craxi
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

10.  Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics.

Authors:  I Esposito; A de Leone; G Di Gregorio; S Giaquinto; L de Magistris; A Ferrieri; G Riegler
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.